General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Martinot–Peignoux M et al. – Treatment monitoring should include both detection of serum HCV–RNA at week 4 to predict SVR and at week 12 to predict non–SVR. The value of all 3 assays was similar for evaluating RVR or EVR. Because of viral load discrepancies the same assay should be used throughout patient treatment follow–up.

Related Articles

Acute hepatitis C and HIV coinfection
The Lancet Infectious Diseases, 11/19/09    Relevance Score: 70%

De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Liver Transplantation, 10/30/09    Relevance Score: 70%

Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C
World Journal of Gastroenterology, 10/30/09    Relevance Score: 70%

FOXP3 Expression in Hepatitis C Virus-Specific CD4+ T Cells During Acute Hepatitis C
Gastroenterology, 10/06/09    Relevance Score: 70%

Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial
Hepatology, 10/14/09    Relevance Score: 69%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address